Results 51 to 60 of about 430 (135)

Multi‐omics profiling of chronic immune‐mediated skin diseases: SKINERGY protocol and strategic evaluation

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 9, Page 1490-1501, September 2026.
The SKINERGY study will investigate six immune‐mediated inflammatory skin diseases through a nationwide collaboration across all Dutch university medical centres. Involving 720 patients and 120 healthy volunteers, it is aimed at generating a high‐quality dataset to identify biomarkers that enable personalized treatment strategies and improved disease ...
N. G. Koster, J. M. P. A. van den Reek, E. M. G. J. de Jong, S. van Beugen, A. I. M. van Laarhoven, I. Haeck, M. de Bruin‐Weller, M. L. Schuttelaar, B. Horvath, A. Gostyński, A. Knulst, M. H. Vermeer, L. Nguyen, L. Gerbens, P. Spuls, M. A. Middelkamp‐Hup, V. Exadaktylos, T. Niemeyer‐van der Kolk, A. R. Schrader, A. M. Sluijmers, J. Versteeg, B. W. M. Arents, I. van Ee, J. L. A. G. van der Zon, M. de Leeuw, T. de Leeuw, P. van den Broek, C. Berkhof, D. Vellinga, S. Weidinger, S. Dubrac, Y. Li, M. van Steensel, M. Marchetti‐Deschmann, M. Maurer, H. van der Zee, J. Damman, D. J. Hijnen, F. Wijk, M. M. B. Seyger, H. Röckmann, D. M. W. Balak, M. B. A. van Doorn, R. Rissmann, on behalf of The Next Generation ImmunoDermatology (NGID) consortium, Rob Vreeken, Eva Cuypers, Boudewijn Lelieveldt, Abdoel El Ghalbzouri, Hanna Niehues, Ellen van den Bogaard, Tom Ederveen, Els van der Pool, Nanda Olde, Debra Trampe, Ellen Stijl‐’t Hart, Lisanne Wezendonk, Johan Westerhuis, Huma Shehwana, Joerg Schreiber, Jeremy Bost, Mie Bech Lukassen, Jimmy Bakker, Juliette Simons, Fauve van den Berge, Colin Spence, Elise Beljaards, Anastasiia Myronenko, Mariona Oliver   +68 more
wiley   +1 more source

Klinische Ergebnisse von Chlormethin‐Gel bei Mycosis fungoides in “sensiblen” Bereichen: Eine retrospektive Fallserie [PDF]

J Dtsch Dermatol Ges
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 11, Page 1447-1450, November 2025.
Tavoletti G, Avallone G, Vezzoli P, Sena P, Marzano A, Berti E, Alberti‐Violetti S.   +6 more
europepmc   +2 more sources

Brentuximab vedotin and radiotherapy for CD30‐positive cutaneous T‐cell lymphoma – a retrospective multicenter analysis

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 4, Page 495-502, April 2026.
Summary Background and Objectives While brentuximab vedotin (BV) and radiotherapy (RTx) are established treatment options for CD30‐positive cutaneous T‐cell lymphoma (CTCL), data on their simultaneous or sequential use regarding efficacy and tolerability remain scarce.
Patrick Schummer, Caroline Glatzel, Philipp Schrüfer, Ingulf Lawrenz, Gabor Dobos, Ulrike Wehkamp, Svea Hüning, René Stranzenbach, Jan P. Nicolay, Matthias Goebeler, Marion Wobser   +10 more
wiley   +1 more source

Behandlung des CD30‐positiven kutanen T‐Zell‐Lymphoms mit Brentuximab vedotin und Strahlentherapie – retrospektive multizentrische Analyse

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 4, Page 495-503, April 2026.
Zusammenfassung Hintergrund und Zielsetzung Während Brentuximab vedotin (BV) oder Strahlentherapie (RTx) gängige Behandlungsoptionen für CD30‐positive kutane T‐Zell‐Lymphome (CTCL) sind, wurde über die Wirksamkeit und Verträglichkeit ihrer gleichzeitigen oder aufeinanderfolgenden Anwendung nur selten berichtet.
Patrick Schummer, Caroline Glatzel, Philipp Schrüfer, Ingulf Lawrenz, Gabor Dobos, Ulrike Wehkamp, Svea Hüning, René Stranzenbach, Jan P. Nicolay, Matthias Goebeler, Marion Wobser   +10 more
wiley   +1 more source

Impact of Ferromagnetic Transition Metals on Different Geometries of Boron Nitride Nanostructures: A DFT Investigation

Advances in Materials Science and Engineering, Volume 2026, Issue 1, 2026.
Recently, transition metal (TM)–doped nanostructures have attracted significant attention due to their enhanced physicochemical characteristics and diverse technological applications. Owing to this, our research employs DFT to analyze the structural, electronic, magnetic, thermodynamic, and optical properties of three geometries of BN nanostructures ...
Md Masud Alam, Aoly Ur Rahman, Bonganur Khan, Noor Ahammad, Md. Alamgir Kabir, Md. Kabir Uddin Sikder, Mohammad Rezwan Habib   +6 more
wiley   +1 more source

Pediatric Hypopigmented Mycosis Fungoides: A Narrative Literature Review of Phototherapy Dosing Regimens

Dermatology Research and Practice, Volume 2026, Issue 1, 2026.
Background Mycosis fungoides is the most common type of childhood‐onset primary cutaneous T‐cell lymphoma, and hypopigmented mycosis fungoides (hMF) is a rare, diversely presenting form of mycosis fungoides that is more common in young populations. Although phototherapy is the most used treatment for pediatric patients with hMF, there are currently no ...
Sarah Muir, Shangyi Fu, Sarah Kesaria, Juan Pinto-Cuberos, Ayezel Munoz-Gonzalez, Alba Guglielmo   +5 more
wiley   +1 more source

A DFT study of adsorption of alkylating-agent chemotherapy drugs on pristine and Ca-, Fe-doped phosphorene

Results in Chemistry
Phosphorene, a two-dimensional monolayer of black phosphorus, has garnered significant attention as a nanomaterial due to its high surface area, tunable electronic properties, and reported biocompatibility.
Samira Kheiri, Saeedeh Sarabadani Tafreshi, Maryam RaeisianAsl   +2 more
doaj   +1 more source

GATA3 as a Prognostic Marker in Early‐Stage Classical Mycosis Fungoides: Association With Disease Progression and Survival Outcomes

Cancer Medicine, Volume 14, Issue 17, September 2025.
ABSTRACT Background and Objective Classical mycosis fungoides (CMF), the most common form of primary cutaneous T‐cell lymphoma, shows marked heterogeneity in disease progression and prognosis, while reliable molecular prognostic markers remain scarce. This study aimed to evaluate the prognostic significance of GATA‐binding protein 3 (GATA3) expression ...
Pengfei Wen, Fan Li, Yao Xie, Wei Chen, Tingting Wang, Xiaoxue Zhuo, Lin Wang   +6 more
wiley   +1 more source

Chlormethine gel is effective for the treatment of skin lesions in patients with early- and late-stage mycosis fungoides in clinical practice

, 2022
Background: Chlormethine gel is a skin-directed therapy used for patients with mycosis fungoides (MF) that showed a favourable risk/benefit profile in a randomized clinical trial. Currently, data on chlormethine gel use in real-world settings are limited.
Nikolaou, V., Georgiou, E., Lampadaki, K., Patsatsi, A., Koumourtzis, M., Dalamaga, M., Papadavid, E., Marinos, L., Stratigos, A.   +8 more
core  

Praxisempfehlungen für die Therapie und Überwachung von Mogamulizumab‐Patienten in Deutschland

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 3, Page 341-356, March 2025.
Zusammenfassung Mycosis fungoides (MF) und Sézary‐Syndrom (SS) sind die häufigsten Subtypen der heterogenen Gruppe der kutanen T‐Zell‐Lymphome (CTCL). Mit der Erweiterung der Therapielandschaft sind in den letzten Jahren neue Behandlungsoptionen verfügbar geworden, allen voran der gegen den C‐C‐Chemokinrezeptor 4 (CCR4) gerichtete monoklonale ...
Chalid Assaf, Nina Booken, Edgar Dippel, Gabor Dobos, Hans‐Theodor Eich, Claus‐Detlev Klemke, Christina Mitteldorf, Jan P. Nicolay, Sebastian Theurich, Marion Wobser, Rudolf Stadler   +10 more
wiley   +1 more source